Related to the number of samples measured, although no statistical differences were found among experimental groups when SUV for [ 18 F]FDG is measured in the intestine, there is an interesting trend showing an attenuation from the LPS effects carried out by peptide VSAK (Fig. 1 C), results that agree with the PET images shown earlier.
← all excerpts
Peptide VSAK maintains tissue glucose uptake and attenuates pro-inflammatory responses caused by LPS in an experimental model of the systemic inflammatory response syndrome: a PET study.
1
—
—